Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Sep 10, 2010


Caris Life Sciences this week named Ian Walker vice president of strategic marketing for Europe and Ian Abercrombie vice president of commercial operations for Europe. The new positions "reflect the company's rapid scaling for an aggressive growth strategy in the region," it said.

Previously Abercrombie was European director of oncology at Genzyme and the program director at UK-based start-up Bioenvision. Walker was most recently global programming director of molecular diagnostics for Novartis.

Stefan Gruenwald was appointed this week to the scientific advisory board of Fibrocell Science, a biotech company focusing on the development of autologous cell therapies.

Gruenwald is the co-founder of San Diego-based proteomics firm Orbigen, which merged in 2004 with Biocarta and Chinese biotech reagent company Jingmei.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.